Cambridge, MA
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.
dynotx.comThese are collections Dyno Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$100,000,000
Seed
$9,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Dyno Therapeutics.